Search results
Results from the WOW.Com Content Network
Hemianopsia, or hemianopia, is a visual field loss on the left or right side of the vertical midline. It can affect one eye but usually affects both eyes. Homonymous hemianopsia (or homonymous hemianopia) is hemianopic visual field loss on the same side of both eyes. Homonymous hemianopsia occurs because the right half of the brain has visual ...
The Peli Lens is a mobility aid for people with homonymous hemianopia. It is also known as “EP” or Expansion Prism concept and was developed by Dr. Eli Peli of Schepens Eye Research Institute in 1999. It expands the visual field by 20 degrees. He tested this concept on several patients in his private practice with great success using 40Δ ...
When the pathology involves both eyes, it is either homonymous or heteronymous. Homonymous hemianopsia Paris as seen with left homonymous hemianopsia. A homonymous hemianopsia is the loss of half of the visual field on the same side in both eyes. The visual images that we see to the right side travel from both eyes to the left side of the brain ...
In the United States there has been an increase in the 5-year relative survival rate between people diagnosed with cancer in 1975-1977 (48.9%) and people diagnosed with cancer in 2007-2013 (69.2%); these figures coincide with a 20% decrease in cancer mortality from 1950 to 2014. [8] Due to innovation in emerging treatments and cancer prevention ...
Atypical teratoid rhabdoid tumor. An atypical teratoid rhabdoid tumor ( AT/RT) is a rare tumor usually diagnosed in childhood. Although usually a brain tumor, AT/RT can occur anywhere in the central nervous system (CNS), including the spinal cord. About 60% will be in the posterior cranial fossa (particularly the cerebellum ).
H&E stain. Specialty. Endocrinology. Multiple endocrine neoplasia type 2B (MEN 2B) is a genetic disease that causes multiple tumors on the mouth, eyes, and endocrine glands. It is the most severe type of multiple endocrine neoplasia, [2] differentiated by the presence of benign oral and submucosal tumors in addition to endocrine malignancies.
In people under age 30, cases remained exceedingly rare. But with such low rates to begin with, any increase can take on a larger significance. The study found that colorectal cancer diagnoses in ...
Progression-free survival. Progression-free survival ( PFS) is "the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse". [1] In oncology, PFS usually refers to situations in which a tumor is present, as demonstrated by laboratory testing, radiologic testing ...